Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 1
1998 1
1999 1
2001 1
2002 2
2003 2
2005 1
2006 5
2007 3
2008 5
2009 3
2010 14
2011 12
2012 7
2013 10
2014 13
2015 5
2016 10
2017 4
2018 9
2019 10
2020 9
2021 12
2022 19
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Medical management of primary hyperparathyroidism.
Bandeira F, de Moura Nóbrega J, de Oliveira LB, Bilezikian J. Bandeira F, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):689-693. doi: 10.20945/2359-3997000000558. Arch Endocrinol Metab. 2022. PMID: 36382758 Free PMC article. Review.
Management of Primary Hyperparathyroidism.
Bilezikian JP, Silverberg SJ, Bandeira F, Cetani F, Chandran M, Cusano NE, Ebeling PR, Formenti AM, Frost M, Gosnell J, Lewiecki EM, Singer FR, Gittoes N, Khan AA, Marcocci C, Rejnmark L, Ye Z, Guyatt G, Potts JT. Bilezikian JP, et al. Among authors: bandeira f. J Bone Miner Res. 2022 Nov;37(11):2391-2403. doi: 10.1002/jbmr.4682. Epub 2022 Oct 17. J Bone Miner Res. 2022. PMID: 36054638 Free article.
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.
Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D'Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP. Khan AA, et al. Among authors: bandeira f. Osteoporos Int. 2017 Jan;28(1):1-19. doi: 10.1007/s00198-016-3716-2. Epub 2016 Sep 9. Osteoporos Int. 2017. PMID: 27613721 Free PMC article. Review.
Bone diseases and the COVID-19 pandemic.
Bandeira F, Bilezikian JP. Bandeira F, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):589-590. doi: 10.20945/2359-3997000000548. Arch Endocrinol Metab. 2022. PMID: 36382748 Free PMC article. No abstract available.
Hormones and bone.
Bandeira F, Lazaretti-Castro M, Bilezikian JP. Bandeira F, et al. Arq Bras Endocrinol Metabol. 2010 Mar;54(2):85-6. doi: 10.1590/s0004-27302010000200001. Arq Bras Endocrinol Metabol. 2010. PMID: 20485894 No abstract available.
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Scirica BM, et al. N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992601 Free article. Clinical Trial.
Primary hyperparathyroidism.
Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Bilezikian JP, et al. Among authors: bandeira f. Nat Rev Dis Primers. 2016 May 19;2:16033. doi: 10.1038/nrdp.2016.33. Nat Rev Dis Primers. 2016. PMID: 27194212 Free PMC article. Review.
Long-term consequences of osteoporosis therapy with denosumab.
Bandeira F, de Oliveira LB, Bilezikian JP. Bandeira F, et al. Arch Endocrinol Metab. 2022 Nov 11;66(5):717-723. doi: 10.20945/2359-3997000000560. Arch Endocrinol Metab. 2022. PMID: 36382761 Free PMC article. Review.
162 results